Open access
5,641
Views
4
CrossRef citations to date
0
Altmetric
Articles
An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan
Hidehisa Saekia Department of Dermatology, Nippon Medical School, Tokyo, JapanView further author information
, Kanako Ishiib Market Access, AbbVie GK, Tokyo, JapanView further author information
, Avani Joshic Dermatology Health Economics and Outcomes Research, AbbVie Inc, Mettawa, IL, USAView further author information
, Arielle G. Bensimond Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USACorrespondence[email protected]
View further author information
, View further author information
Hongbo Yangd Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USAView further author information
& Isao Kawaguchib Market Access, AbbVie GK, Tokyo, JapanView further author information
Pages 229-239
|
Received 27 Feb 2020, Accepted 15 Mar 2020, Published online: 17 Apr 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.